Back to results
US 2005/0032124 A1Published application
Identification of genotype-selective agents for treating Huntington's disease
OwnerBrent Stockwell, Benjamin Hoffstrom +1inventors
InventorsBrent Stockwell, Benjamin Hoffstrom, Hemant Varma
Life of this patent
Estimating the term…
Abstract
The present invention relate to methods of identifying a genotype-selective agent. In certain embodiments, the invention relates to agents that selectively suppress huntingtin-induced toxicity to engineered neuronal cells.
Claims7
A method of identifying an agent that selectively suppresses toxicity to a neuronal cell, comprising:
- (a) contacting test cells, which are engineered neuronal cells, with a candidate agent;
- (b) determining viability of test cells contacted in (a) with the candidate agent;
- and
- (c) comparing the viability of test cells determined in (b) with an appropriate control,
- wherein if the viability of the test cells is more than that of the control cells, then an agent that selectively suppresses toxicity to neuronal cells is identified.
2 more elements
Dependencies are inferred from the claim text.